| Report ID | 277634 |
| Drug Identification Number | 02513420 |
| Brand name | ARSENIC TRIOXIDE FOR INJECTION |
| Common or Proper name | ARSENIC TRIOXIDE FOR INJECTION |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | ARSENIC TRIOXIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10ML |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2026-02-09 |
| Estimated end date | 2026-02-27 |
| Actual end date | 2026-02-23 |
| Shortage status | Resolved |
| Updated date | 2026-02-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2026-02-25 | French | Compare |
| v5 | 2026-02-25 | English | Compare |
| v4 | 2026-02-23 | French | Compare |
| v3 | 2026-02-23 | English | Compare |
| v2 | 2026-02-09 | French | Compare |
| v1 | 2026-02-09 | English | Compare |
Showing 1 to 6 of 6